-
Study aim
-
Determining whether correcting iron deficiency in pregnancy helps to improve thyroid function
-
Design
-
Clinical trial with control group, with parallel groups, single blind, randomized, phase 3 on 48 patients, all information will be done using spss version 21.
-
Settings and conduct
-
This study will be conducted as a randomized clinical trial study on pregnant women with acquired hypothyroidism referred in the second trimester of pregnancy. This study is a blind strain and the participants are blind and uninformed.
-
Participants/Inclusion and exclusion criteria
-
Inclusion criteria: pregnant mothers with a positive pregnancy test result, age 20 to 35 years, and the pregnancy time is the second trimester of pregnancy, and informed consent will be obtained from all patients. Exclusion criteria were: suffering from chronic diseases (such as diabetes). Gastrointestinal intolerance of iron pills, all cancers and neoplasms, especially thyroid cancer.
-
Intervention groups
-
.The study will be one-way blind in two groups, group A is the control group and group B is the intervention group. At the beginning of the study, 5 cc of blood will be taken from each patient, then for the intervention group, ferrous sulfate tablets, each tablet containing 50 mg of elemental iron, will be given two tablets equivalent to 100 mg of elemental iron daily, and for the control group, placebo tablets will be given daily. Two numbers will be given. After three months, 5 cc of blood will be collected from each group and the tests will be repeated in the same laboratory with the same kits.
-
Main outcome variables
-
Ferritin - TSH _hemoglobin _T3_T4 _ TIBC